NORTHBROOK, Ill., April 22, 2008 (PRIME NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), which develops, manufactures and markets advanced molecular diagnostics systems, will report its results for the first quarter of 2008 after the market closes on Tuesday, May 13, 2008. The company will also hold a live investor conference call and webcast at 5:00 P.M., Eastern Standard Time.
The teleconference can be accessed by dialing 888-713-4209 (U.S./Canada) or 617-213-4863 (international), participant code 77860716. The call will also be broadcast live over the Internet and can be accessed by interested parties at the Investor Relations tab on the Nanosphere website: www.nanosphere.us.
Participants may pre-register for the call at: https://www.theconferencingservice.com/prereg/key.process?key=P6EYXGWQ8. Pre-registrants will be issued a pin number to use when dialing into the live call, which will provide quick access to the conference by bypassing the operator upon connection. For interested individuals unable to join the call or webcast, a replay will be available through May 27, 2008, by dialing 888-286-8010 or for international calls 617-801-6888, pass code 17835853, or on the company's website.
Annual Meeting
Nanosphere also announced it will hold its first annual shareholders meeting as a public company, in downtown Chicago, at 9:00 A.M., Central Time, on Thursday, May 29. The meeting will take place at the Westin Michigan Avenue Chicago hotel, located at 909 North Michigan Avenue.
The agenda for the meeting will include:
-- Election of directors
-- Ratify the audit committee's selection of Deloitte & Touche LLP
as the company's independent auditors
-- Transact such other business as may properly come before
the annual meeting.
After completion of the annual meeting's formal agenda, William Moffitt, Nanosphere' President and Chief Executive Officer, will provide an overview discussion of the company's progress in 2007 and early 2008.
About Nanosphere, Inc.
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene(r) System for direct genomic and ultra-sensitive protein detection. This easy-to-use and cost-effective platform enables simple, low-cost and highly sensitive genomic and protein testing on a single platform. Nanosphere is based in Northbrook, IL. Additional information is available at www.nanosphere.us.
The Nanosphere, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4344